DFINE, Inc. Announces Prospective Clinical Trial For Breakthrough Therapy To Treat Spinal Fractures Caused By Multiple Myeloma

Links shared publicly online about this topic.

  • 237
    total visits

DFINE, Inc. Announces Prospective Clinical Trial For Breakthrough Therapy To Treat Spinal Fractures Caused By Multiple Myeloma

medicalnewstoday.com —

DFINE, Inc., the developer of minimally invasive radio frequency (RF) targeted therapies for the treatment of vertebral pathologies, announced today that H. Lee Moffitt Cancer Center and Research

View full resource at medicalnewstoday.com

Tags: Emergency, Fracture, Cancer, Multiple Myeloma, Disease and Condition, Clinical Trial, Pathology

  • Share

Most Recently Shared on June 7, 2011 at 8:37 am By:

medical_tweets medical_tweets

DFINE, Inc. Announces Prospective Clinical Trial For Breakthrough Therapy To Treat Spinal Fractures Caused By Multiple.. http://dld.bz/ac2wY

11 months ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Clinical Trials MNT Clinical Trials

MNT Bones/Orthopedic MNT Bones/Orthopedic

Advertisement